Literature DB >> 3016305

Molecular characterization of Marek's disease herpesvirus B antigen.

R J Isfort, I Sithole, H J Kung, L F Velicer.   

Abstract

The Marek's disease herpesvirus (MDHV) B antigen (MDHV-B) was identified and molecularly characterized as a set of three glycoproteins of 100,000, 60,000, and 49,000 apparent molecular weight (gp100, gp60, and gp49, respectively) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) after immunoprecipitation from [35S]methionine-labeled infected cells by specific rabbit antiserum directed against MDHV-B (R alpha B), as previously determined by immunodiffusion. Further identification was accomplished by blocking this immunoprecipitation with highly purified MDHV-B. The same set of three polypeptides was also immunoprecipitated from [35S]methionine- and 14C-labeled infected cells with two other sera shown to have anti-B activity, i.e., rabbit anti-MDHV-infected-cell plasma membrane (R alpha PM) and immune chicken serum from birds naturally infected with MDHV. The three herpesvirus of turkeys (HVT) B-antigen (HVT-B) glycoproteins immunoprecipitated with all three sera containing anti-B activity were also shown to be identical in size to those of MDHV-B by immunoprecipitation and SDS-PAGE. These data serve to clarify the molecular identification of the polypeptides found in common between MDHV and HVT by linking them to MDHV-B, previously identified only by immunodiffusion, and to a similarly sized set of immunologically related common glycoproteins called gp100, gp60, and gp49, detected with monoclonal antibody by other workers. Tunicamycin inhibition of N-linked glycosylation resulted in either nonglycosylated or O-linked glycosylated putative precursors of MDHV-B and HVT-B with apparent molecular weights of 88,000, called pr88, and 44,000, tentatively called pr44, both immunoprecipitable with all three sera. However, the relationships of these two polypeptides to each other and to the overall precursor-processing relationship of the MDHV-B complex remains to be elucidated. The three fully glycosylated B-antigen polypeptides were not connected by disulfide linkage. Collectively, the data presented here and by others support the conclusion that all three glycoproteins now identified as gp100, gp60, and gp49 have MDHV-B determinants. Finally, detection of the same three polypeptides with well-absorbed R alpha PM, which was directed against purified infected-cell plasma membranes, suggests that at least one component of the B-antigen complex has a plasma membrane location in the infected cell.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016305      PMCID: PMC253091     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Synthesis, processing, and secretion of the Marek's disease herpesvirus A antigen glycoprotein.

Authors:  R J Isfort; R A Stringer; H J Kung; L F Velicer
Journal:  J Virol       Date:  1986-02       Impact factor: 5.103

3.  Demonstration of three major species of pseudorabies virus glycoproteins and identification of a disulfide-linked glycoprotein complex.

Authors:  N Lukàcs; H J Thiel; T C Mettenleiter; H J Rziha
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  Structure of the murine leukemia virus envelope glycoprotein precursor.

Authors:  O N Witte; D F Wirth
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Identification with monoclonal antibodies of glycoproteins of Marek's disease virus and herpesvirus of turkeys related to virus neutralization.

Authors:  K Ikuta; S Ueda; S Kato; K Hirai
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

8.  Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen.

Authors:  C Glaubiger; K Nazerian; L F Velicer
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

9.  Alterations of the immunological specificity of plasma membranes from cells infected with Marek's disease and turkey herpes viruses.

Authors:  O R Kaaden; B Dietzschold
Journal:  J Gen Virol       Date:  1974-10       Impact factor: 3.891

10.  Induction of virus-neutralizing antibody by glycoproteins isolated from chicken cells infected with a herpesvirus of turkeys.

Authors:  A P Wyn-Jones; O R Kaaden
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

View more
  11 in total

1.  Identification of the gene encoding Marek's disease herpesvirus A antigen.

Authors:  R J Isfort; H J Kung; L F Velicer
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

2.  Synthesis and processing of the Marek's disease herpesvirus B antigen glycoprotein complex.

Authors:  I Sithole; L F Lee; L F Velicer
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

3.  Monospecific antibodies to Marek's disease virus antigen B dimer (200 kDa) and monomer (130 and 60 kDa) glycoproteins neutralize virus infectivity and detect the antigen B proteins in infected cell membranes.

Authors:  I Davidson; Y Becker; M Malkinson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Identification of subgroups of bovine respiratory syncytial virus.

Authors:  J C Baker; E G Wilson; G L McKay; R J Stanek; W J Underwood; L F Velicer; M A Mufson
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins.

Authors:  Z Z Cui; D Yan; L F Lee
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

6.  Characterization of the gene encoding herpesvirus of turkeys gp57-65: comparison to Marek's disease virus gp57-65 and herpes simplex virus glycoprotein C.

Authors:  P M Coussens; M R Wilson; H Camp; H Roehl; R J Isfort; L F Velicer
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

7.  Transcriptional analysis of Marek's disease virus glycoprotein D, I, and E genes: gD expression is undetectable in cell culture.

Authors:  X Tan; P Brunovskis; L F Velicer
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells.

Authors:  X B Chen; P J Sondermeijer; L F Velicer
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

9.  Marek's disease virus serotype-1 antigens A and B and their unglycosylated precursors detected by Western blot analysis of infected cells.

Authors:  I Davidson; M Malkinson; Y Becker
Journal:  Virus Genes       Date:  1988-10       Impact factor: 2.332

10.  Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.

Authors:  M Niikura; Y Matsuura; D Endoh; M Onuma; T Mikami
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.